PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Nov. (CADTH Optimal Use Report, No. 1.2B.)

APPENDIX 2DEFINITIONS OF ANTICOAGULATION MANAGEMENT SERVICES

Usual care may be defined as warfarin dose adjustment managed by a physician working in a private practice setting that not only addresses anticoagulation management, but also other medical problems.11 Physicians in this setting use their own judgment without access to specialized anticoagulation tools, or specialized anticoagulation staff and services.11,12

Specialized anticoagulation services are an approach to improving anticoagulant control. These services can generally be defined as tertiary or community hospital-based anticoagulation clinics, primary care settings, point-of-care testing and dose adjustment by community pharmacies, and patient self-testing or patient self-management using a point-of-care device.10 The primary care anticoagulation setting involves a family practice group or family health team where nurses, pharmacists, or physicians are responsible for managing warfarin therapy.10 Primary care settings and hospital-based anticoagulation clinics may use computerized decision-support applications or other means to guide warfarin dosing.7,10

Of note, based on the above definitions, the following categories of specialized anticoagulation services were developed for the purpose of conducting the environmental scanning:

  • Hospital-based anticoagulation clinics (tertiary care and community hospitals)
  • Primary care settings (family practice group or family health team, in which RN/NP [nurses], RPh/Pharm D [pharmacists], or MD [physicians] may be responsible for managing warfarin therapy)
  • Point-of-care testing and dose adjustment by community pharmacies.
Copyright © 2011 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Cover of Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies
Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: Review of Canadian Economic Studies [Internet].
CADTH Optimal Use Report, No. 1.2B.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...